Skip to main content

Table 5 Serotype distribution among pneumococcal strains displaying resistance to at least one antibiotic class (n = number of strains, % = percent of strains per geographic region).

From: Risk factors for nasopharyngeal carriage of drug-resistant Streptococcus pneumoniae: data from a nation-wide surveillance study in Greece

 

Athens

(n, %)

Halkida

(n, %)

Thessaloniki

(n, %)

Ioannina

(n, %)

Alexandroupolis

(n, %)

Herakleion

(n, %)

Peloponnese

(n, %)

Total

(n,%)

PCV7* serotypes

80 (70.17)

42 (73.68)

33 (58.92)

10 (76.92)

6 (54.55)

25 (75.76)

30 (90.91)

226 (71.29)

19F

32 (28.07)

20 (35.09)

9 (16,07)

2 (15.38)

3 (27.27)

11 (33.33)

10 (30.3)

87 (27.44)

14

10 (8.77)

6 (10.53)

10 (17.86)

  

11 (33.33)

3 (9.09)

40 (12.62)

9V

20 (17.54)

 

2 (3.57)

2 (15.38)

  

10 (30.3)

34 (10.73)

23F

10 (8.77)

6 (10.53)

6 (10.71)

5 (38.46)

1 (9.09)

1 (3.04)

4 (12.13)

33 (10.41)

6B

8 (7.02)

10 (17.54)

5 (8.93)

1 (7.69)

2 (18.18)

2 (6.06)

2 (6.06)

30 (9.46)

18C

  

1 (1.79)

   

1 (3.03)

2 (0.63)

PCV7-related serotypes

17 (14.92)

10 (17.55)

11 (19.66)

0

2 (18.18)

4 (12.12)

0

43 (13.56)

6A

7 (6.14)

3 (5.26)

5 (8.93)

 

0

2 (6.06)

 

17 (5.36)

Other related

10 (8.78)

7 (12.29)

6 (10.73)

 

2 (18.18)

2 (6.06)

 

26 (8,20))

Non PCV7 serogroups

10 (8.77)

3 (5.26)

8 (14.28)

3 (23.08)

1 (9.09)

2 (6.06)

3 (9.09)

32 (10.1)

Nontypeable strains

7 (6.14)

2 (3.51)

4 (7.14)

0

2 (18.18)

2 (6.06)

0

16 (5.05)

Total

114 (100)

57 (100)

56 (100)

13 (100)

11 (100)

33 (100)

33 (100)

317 (100)

  1. *PCV7: heptavalent pneumococcal conjugate vaccine